This reflects broader metabolic consequences and underlines mitochondrial bioenergetics as an attractive target for therapeutic strategies aimed at enhancing insulin secretion and countering diabetes-related pathologies [58,62]. The gene discussed is INS; the disease is diabetes mellitus.